IL1F10 and lung disorder: The therapeutic potential of IL‐38 to reduce inflammation‐mediated lung damage has been investigated in mouse models of lung disease or injury following cecal ligation and puncture,20 intranasal lipopolysaccharide (LPS),20 intraperitoneal poly(I:C) challenge,23 and bleomycin‐induced pulmonary fibrosis.24